Zielinski J J, Haidukewych D, Leheta B J
Ther Drug Monit. 1985;7(1):51-3.
By intrapatient comparison at constant phenytoin (PHT) dose, the effect of carbamazepine (CBZ) comedication on PHT was studied in a group of 24 epileptic outpatients. In half of the patients with steady-state PHT plasma concentration, a significant increase of this concentration was noted after CBZ was added to their regimen. Twenty percent showed clinical manifestations of acute drug toxicity initially thought to be CBZ related. The mean PHT plasma concentration for the 12 patients (22.7 +/- 5.64 micrograms/ml) as well as concentration/dose ratio for PHT (4.61 +/- 1.65 micrograms/ml plasma per mg/kg/day dose) was significantly higher (p less than 0.001) with concomitant administration of CBZ than when PHT was given alone: PHT concentration, 12.54 +/- 3.93 micrograms/ml and PHT concentration/dose ratio, 2.52 +/- 0.78 micrograms/ml plasma per mg/kg/day dose. Those patients with higher PHT plasma concentrations seem to be at higher risk of PHT toxicity due to CBZ comedication.
通过在苯妥英(PHT)剂量恒定的情况下进行患者内比较,在一组24名癫痫门诊患者中研究了卡马西平(CBZ)联合用药对PHT的影响。在一半稳态PHT血浆浓度的患者中,在其治疗方案中添加CBZ后,该浓度显著升高。20%的患者最初出现被认为与CBZ相关的急性药物毒性临床表现。与单独给予PHT时相比,12名患者同时服用CBZ时的平均PHT血浆浓度(22.7±5.64微克/毫升)以及PHT的浓度/剂量比(每毫克/千克/天剂量的血浆中4.61±1.65微克/毫升)显著更高(p<0.001):PHT浓度为12.54±3.93微克/毫升,PHT浓度/剂量比为每毫克/千克/天剂量的血浆中2.52±0.78微克/毫升。那些PHT血浆浓度较高的患者似乎因CBZ联合用药而有更高的PHT毒性风险。